primary mediastinal B-cell lymphoma (PMBCL)

September 12, 2019September 12, 2019

Opdivo-Adcetris Combo Shows Promise in Advanced PMBL Patients in Trial

News

Combining Opdivo (nivolumab) with Adcetris (brentuximab vedotin) could be a promising option for people with advanced primary mediastinal B-cell lymphoma (PMBL), an aggressive and hard-to-treat disease, results from the CheckMate-436 ... Read more

December 15, 2017December 15, 2017

FDA Reviews Application for Keytruda in Mediastinal B-cell Lymphoma

News

The U.S. Food and Drug Administration (FDA) agreed to review Merck’s application to add relapsed or refractory primary mediastinal large B-cell lymphoma (PMBCL) to the list of cancers treated with ... Read more

October 17, 2016

Kite Appoints European Head to Prepare for Potential Launch of Lead Lymphoma Therapy

News

Kite Pharma has appointed Chris Nowers as its new Head of Europe to oversee European commercial operations, raise awareness of Kite’s pipeline portfolio of CAR and T-cell receptor (TCR) therapy ... Read more